RT Journal Article
SR Electronic
T1 On an optimal testing strategy for workplace settings operating during the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.22.20248752
DO 10.1101/2020.12.22.20248752
A1 Hernandez, X.
A1 Valentinotti, S.
YR 2020
UL http://medrxiv.org/content/early/2020/12/24/2020.12.22.20248752.abstract
AB High quality daily testing for the presence of the SARS-CoV-2 in workplace settings has become part of the standard and mandatory protection measures implemented widely in response to the current pandemic. Such tests are often limited to a small fraction of the attending personnel due to cost considerations, limited availability and processing capabilities and the often cumbersome requirements of the test itself. A maximally efficient use of such an important and frequently scarce resource is clearly required. We here present an optimal testing strategy which minimises the presence of pre-symptomatic and asymptomatic members of the population, derived under a series of simplifying assumptions, which however retain many of the generalities of the problem and yield robust results, as verified through a number of numerical simulations. We show that reduction in overall infected-person-days, IPD, by significant percentages can be achieved, for fixed numbers of tests per day of 5% and 10% of the population, of 30% and 50% in the IPD numbers, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of the first author was partly supported by UNAM-DGAPA grant IN106220 and Consejo Nacional de Ciencia y Tecnologia CONACyT, Mexico. No payment was recieved in connection to any part of this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no relevant IRB body associated with this study, which complies with all ethical guidelines of the Universidad Nacional Autonoma de Mexico.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data not publicly available has been used.